DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 2.20% to $130.28 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
This was the stock's third consecutive day of losses.
Gilead Sciences Inc. closed 17.17% below its 52-week high of $157.29, which the company achieved on February 11th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.72% to $250.61, Pfizer Inc. $(PFE)$ rose 0.77% to $24.94, and Abbott Laboratories $(ABT)$ fell 1.96% to $99.67.
Trading volume (8.2 M) eclipsed its 50-day average volume of 7.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 21, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments